University College London, London, UK
Professor Mohan Edirisinghe holds the established Bonfield Chair of Biomaterials in the Department of Mechanical Engineering at University College London (UCL). He has actively pursued advanced materials processing, forming and manufacturing research, for over 25 years publishing over 500 journal papers with a H-index of 68 and over 16,000 citations. In addition, his research has won many prizes including the Royal Society Brian Mercer (Innovation) Feasibility Award an unprecedented three times (2005, 2009 and 2013), the 2010 Materials Science Venture Prize and the 2012 Presidents Prize of the UK Biomaterials Society. In 2015 he was elected as a Fellow of The Royal Academy of Engineering in the UK. In 2017 he was the recipient of The Royal Academy of Engineering Armourers & Brasiers prize for excellence in Materials Engineering and the Premier IOM3 Chapman Medal. In 2020, he was elected as a Fellow of The European Academy of Sciences. In the Queens New Year Honours 2021 he was appointed OBE for his services to Biomedical Engineering.
State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Professor Zhiyong Qian received his Ph.D. degree in Organic Chemistry from Chengdu Institute of Organic Chemistry, Graduate School of Chinese Academy of Sciences. After finishing his postdoctoral training on nano-biomaterials at Sichuan University, he joined in State Key Laboratory of Biotherapy at Sichuan University as a full professor. His major research interest is biomaterials for cancer therapy and tissue engineering. Professor Qian has published over 100 papers on international journals including Science Advances, Advanced Materials, ACS Nano, Nao Today, Advanced Functional Materials and so on. Meanwhile, he has developed “Injectable Docetaxel Polymer Micelles” and “Injectable Paclitaxel Polymer Micelles” approved with CFDA and transferred NDA to pharmaceutical industry for clinical trials. He has served as Associate Editor of Signal Transduction and Targeted Therapy, Chinese Chemical Letters and Journal of Biological Engineering, and Editorial Board Member of several International Journals.
Wenzhou Institute, University of Chinese Academy of Sciences, China
Dr. Min Wu is a full professor at Wenzhou Institute, University of Chinese Academy of Sciences and Visiting Professor at Harvard University and is known for his numerous, original contributions to host immune response to and pathogenesis of bacteria, especially Pseudomonas aeruginosa. He has published over 200 research and review articles involving infection immunity mechanisms and antimicrobial therapeutic materials in high-quality journals, such as Nat Microbiol, Nat Commun, Nature, Cell Host Microbe, Science Signal, and PNAS. He is highly interested in small or non-coding RNA regulation, nanomaterials, and precision gene editing research to ultimately provide better solutions for diagnostic, preventive, and therapeutic products for refractory and pandemic diseases. He is (was) an associate editor and editorial board member of more than ten journals (Nanomedicine, J IMMUNOL). He was a chair or session chair of many international conferences, such as Cold Spring Harbor Asia, and was invited to speak at academic conferences such as Gordon Res Conferences. He is a reviewer of many grant funding agencies (e.g. NIH) and a reviewer for many journals (i.e. NAT Rev Cell Mol Biol, NAT MICROBIOL, Nat Commun, PNAS etc.). He has also received many awards including AHA, AAI, and FAMRI Research Career Funds.
Gary L. Bowlin, The University of Memphis, Memphis, TN, USA
Biqiong Chen, Queen's University Belfast, Belfast, UK
Gang Liu, Xiamen University, Xiamen, China
Pralay Maiti, School of Materials Science and Technology, Indian Institute of Technology, Varanasi, India
Kanyi Pu, Nanyang Technological University, Singapore
Ja-Hyoung Ryu, Ulsan National Institute of Science & Technology, Ulsan, Korea
Qun Wang, Iowa State University, Ames, IA, USA
Yu-quan Wei, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
Jun Wu, Sun Yat-Sen University, Guangzhou, China
Yingqiu Xie, Nazarbayev University, Astana, Kazakhstan
Hu Yang, Missouri University of Science and Technology, Rolla, MO, USA
Zhimou Yang, NanKai University, Tianjin, China
Andrew Yeudall, The Dental College of Georgia at Augusta University, Augusta, GA, USA
Wei Chen, Huazhong University of Science and Technology, Wuhan, China
Marlus Chorilli, São Paulo State University, Arararaquara, SP, Brazil
Weisheng Guo, Guangzhou Medical University, Guangzhou, China
Nongyue He, Southeast University, Nanjing, China
Yi Hong, The University of Texas at Arlington, Arlington, TX, USA
Jung Seung Lee, Department of Biomedical Engineering, Sungkyunkwan University, Suwon, Korea
Zhen Li, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, China
Yong-beom Lim, Yonsei University, Seoul, Korea
Zhiqun Lin, Georgia Institute of Technology, Atlanta, GA, USA
Jinfeng Liao, Sichuan University, Chengdu, China
Ebrahim Mostafavi, Stanford University, Stanford, CA, USA
Roger Narayan, University of North Carolina and North Carolina State University, Raleigh, NC, USA
Joaquim Miguel Oliveira, University of Minho, Braga, Portugal
Chitta Ranjan Patra, CSIR-Indian Institute of Chemical Technology, Hyderabad, India
Yong Wang, Pennsylvania Sate University, State College, PA, USA
Gareth Williams, UCL School of Pharmacy, University College London, UK
Wei Wu, School of Pharmacy, Fudan University, Shanghai, China
Chenjie Xu, City University of Hong Kong, Hong Kong, China
Dimitrios I. Zeugolis, Regenerative, Modular & Developmental Engineering Laboratory (REMODEL), University College Dublin (UCD), Dublin, Ireland
Xin Zhao, The Hong Kong Polytechnic University, Hong Kong, China
Chenchen Zhou, Sichuan University, Chengdu, China
Senior Editor
Bing Han joined MedComm – Biomaterials and Applications in January 2024. After graduated from Huazhong University of Science and Technology with bachelor and master of medicine, he received his Doctor of medicine from Ludwig-Maximillians University Munich where he studied stress and programmed cell death. He then continued to carry out his postdoctoral research on stress and immunity during spaceflight in Hospital of LMU Munich. At present he is the Senior Editor of MedComm – Biomaterials and Applications.
Publishing Development, Health Sciences, Beijing, China